Designed for the changing healthcare landscape.

Precision Medicine Group was founded in 2012 to transform the process of bringing new drugs to market by integrating science, technology, data, and human expertise. We invest organically and acquire capabilities to address the fundamental changes in healthcare necessary for global health and outcomes improvement.

Precision Medicine Group Leadership Team

Our leadership team has an expansive knowledge of the industry, spanning clinical development through commercialization. Each of our leaders shares a proven track record of success in leading growth, supporting a client-first approach and driving our shared mission—to accelerate development and access to breakthrough treatments and improve the lives of patients in need.

Margaret Keegan

Chief Executive Officer

Chad Clark

President and Chief Operating Officer

Jake Graetz

Corporate Development Officer

Karl Deonanan

Chief Financial Officer

Matt Dezee

Chief Transformation and Strategy Officer

Stacey Hanna

General Counsel & Chief Compliance Officer

Tina Murphy

Chief People Officer

Precision Medicine Group Board of Directors

Our board of directors includes our co-founders, industry veterans, successful entrepreneurs and visionaries. Each has deep knowledge of the biotech and pharma industry and rich insights on the capabilities required to bring the next generation of novel therapies to market.